Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia

Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia

<strong>Background<br></strong> Dihydroartemisinin–piperaquine has been Indonesia’s first-line anti-malarial treatment since 2008. Annual therapeutic efficacy studies (TES) done in the last 12 years showed continued high treatment efficacy in uncomplicated Plasmodium falciparum mal...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ: Rahmasari, FV, Asih, PBS, Rozi, IE, Wangsamuda, S, Risandi, R, Dewayanti, FK, Permana, DH, Syahrani, L, Prameswari, HD, Basri, HH, Bustos, MDG, Charunwatthana, P, Dondorp, AM, Imwong, M, Syafruddin, D
Ձևաչափ: Journal article
Լեզու:English
Հրապարակվել է: BioMed Central 2023

Նմանատիպ նյութեր